Vitrakvi: Presence of contamination in affected lot
Last updated
Summary
Product
Vitrakvi
Issue
Health products - Contamination
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Vitrakvi |
Vitrakvi |
DIN 02490331 |
Solution |
LAROTRECTINIB (LAROTRECTINIB SULFATE) 20mg/ml |
2133134 |
Issue
Presence of contamination in affected lot
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Bayer Inc.
2920 Matheson Blvd E, Mississauga
ON, Canada, L4W 5R6
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74568
Get notified
Receive notifications for new and updated recalls and alerts by category.